Company Overview and News


Add SSKN
to your dashboard

Headline News

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good day and welcome to the STRATA Skin Sciences’ Third Quarter 2017 Earnings Conference Call. Today’s conference is being recorded. (4-0)

BRIEF-Leviticus Partners reports 9.69 pct passive stake in Strata Skin Sciences

2017-11-02 reuters
* Says reports 9.69 pct passive stake in Strata Skin Sciences Inc as of Oct 24, 2017 - SEC filing‍​ Source text - (bit.ly/2h6vUO5) (4-1)

SSKN / Strata Skin Sciences, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-02 fintel.io
Strata Skin Sciences, Inc. (NASDAQ:SSKN) has 19 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 836,595 shares. Largest shareholders include Leviticus Partners L P, Sabby Management, Llc, Bridgeway Capital Management Inc, Broadfin Capital, LLC, and BlackRock Inc.. (36-2)

STRATA Skin Sciences'(SSKN) CEO Frank McCaney on Q2 2017 Results - Earnings Call Transcript

2017-08-10 seekingalpha
Good day and welcome to the STRATA Skin Sciences Second Quarter 2017 Earnings Conference Call. Today's conference is being recorded.

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q1 2017 Results - Earnings Call Transcript

2017-05-11 seekingalpha
Good day and welcome to the STRATA Skin Sciences First Quarter 2017 Earnings Conference Call. Today's conference is being recorded. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session and instructions on how to queue will be provided at that time.

STRATA Skin Sciences Release: Psoriasis Drugs Among Leaders In Drug Side Effect Reporting

2017-03-31 devicespace
HORSHAM, PA, March 31, 2017 /PRNewswire/ - According to a recent USA Today Network Exclusive analysis*, the number of drug side effect reports filed with the U.S. Food and Drug Administration (FDA) has increased five-fold from 2004 to 2015. This equated to more than 1.2 million reports in 2015.1

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q4 2016 Results - Earnings Call Transcript

2017-03-10 seekingalpha
Good day ladies and gentlemen and welcome to the STRATA Skin Sciences Fourth Quarter and Full-Year 2016 Earnings Conference Call. Please note, today’s conference is being recorded.

CorMedix Inc. Announces New Appointments to Senior Leadership Team

2017-02-01 accesswire
BEDMINSTER, NJ / ACCESSWIRE / February 1, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases, today announced the addition of two members to its senior leadership team. Robert W. Cook was appointed Chief Financial Officer and Judith R. Abrams, M.D., FRCPC, was appointed to the new role of Chief Medical Officer.

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q3 2016 Results - Earnings Call Transcript

2016-11-11 seekingalpha
Good day and welcome to the STRATA Skin Sciences Third Quarter 2016 Earnings Conference Call. Today’s call is being recorded.

Aesthetic Lasers Market Analysis by Application, and Segment Forecasts to 2024

2016-09-22 prnewswire
NEW YORK, Sept. 21, 2016 /PRNewswire/ -- The global aesthetic lasers market is expected to reach USD 1.8 billion by 2024, according to a new report by Grand View Research, Inc. The demand is expected to upsurge due to aging population, high prevalence of obesity, and wide range of safe and effective treatments. Moreover, growing awareness about the safety and efficacy of lasers coupled with its ease of use is also expected to propel its cosmetic applications.

STRATA Skin Sciences' (SSKN) CEO Michael Stewart on Q1 2016 Results - Earnings Call Transcript

2016-09-19 seekingalpha
Good day and welcome to the STRATA Skin Sciences First Quarter 2016 Earnings Call. Today’s conference is being recorded. At this time, all participants are in a listen-only mode. [Operator Instructions] I would like to remind everyone that this conference once again is being recorded.

MELA Sciences will be STRATA Skin Sciences on January 5

2016-09-18 seekingalpha
On January 5, MELA Sciences (MELA +1.8%) will change its name to STRATA Skin Sciences, reflecting a broader presence in and commitment to dermatology. The new symbol, effective at the open, will be SSKN.

STRATA Skin Sciences' (SSKN) CEO Michael Stewart on Q4 2015 Results - Earnings Call Transcript

2016-09-18 seekingalpha
Good day, and welcome to the STRATA Skin Sciences Fourth Quarter 2015 Earnings Call. Today’s conference is being recorded. At this time, all participants are in a listen-only mode. [Operator Instructions]. I would like to remind everyone that this conference is being recorded.

CUSIP: 86272A107